Serine/threonine kinase 11 (STK11) mutations and immunotherapy resistance in patients with non-small cell lung cancer.

Richie Uba,Luis E. Raez,Katerine Dumais,Frank Gentile,H. Powery,Gelenis Calzadilla Domingo,P. Izquierdo,Brian Hunis

Serine/threonine kinase 11 (STK11) mutations and immunotherapy resistance in patients with non-small cell lung cancer.

2020

Richie Uba
Luis E. Raez
Katerine Dumais
Frank Gentile
H. Powery
Gelenis Calzadilla Domingo
P. Izquierdo
Brian Hunis

e15055Background: There is immune evasion and resistance to checkpoint inhibitors (CPI). Programmed death-ligand 1 (PD-L1) and Tumor mutational burden (TMB) might help us predict response, but we h...

Keywords:

STK11
Lung cancer
Serine/threonine-specific protein kinase
in patient
non small cell
Pathology
Immunotherapy
Medicine
Cancer research

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations